Next Article in Journal
Assessment and Modeling of Plasmonic Photothermal Therapy Delivered via a Fiberoptic Microneedle Device Ex Vivo
Next Article in Special Issue
Physiologically Based Pharmacokinetic (PBPK) Model of Gold Nanoparticle-Based Drug Delivery System for Stavudine Biodistribution
Previous Article in Journal
Cyclodextrin-Modified Nanomaterials for Drug Delivery: Classification and Advances in Controlled Release and Bioavailability
Previous Article in Special Issue
Pharmacokinetics and Pharmacodynamics of T-Cell Bispecifics in the Tumour Interstitial Fluid
Article

A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice

1
Medical Radiation Physics, Department of Nuclear Medicine, Ulm University, 89081 Ulm, Germany
2
Biophysics and Medical Imaging Program, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus 44839, Palestine
3
Department of Nuclear Medicine, Ulm University, 89081 Ulm, Germany
*
Author to whom correspondence should be addressed.
Academic Editors: Matilde Merino-Sanjuán, Virginia Merino Sanjuán and Victor Mangas Sanjuán
Pharmaceutics 2021, 13(12), 2132; https://doi.org/10.3390/pharmaceutics13122132
Received: 15 October 2021 / Revised: 4 December 2021 / Accepted: 7 December 2021 / Published: 10 December 2021
In vivo alpha particle generators have great potential for the treatment of neuroendocrine tumors in alpha-emitter-based peptide receptor radionuclide therapy (α-PRRT). Quantitative pharmacokinetic analyses of the in vivo alpha particle generator and its radioactive decay products are required to address concerns about the efficacy and safety of α-PRRT. A murine whole-body physiologically based pharmacokinetic (PBPK) model was developed for 212Pb-labeled somatostatin analogs (212Pb-SSTA). The model describes pharmacokinetics of 212Pb-SSTA and its decay products, including specific and non-specific glomerular and tubular uptake. Absorbed dose coefficients (ADC) were calculated for bound and unbound radiolabeled SSTA and its decay products. Kidneys received the highest ADC (134 Gy/MBq) among non-target tissues. The alpha-emitting 212Po contributes more than 50% to absorbed doses in most tissues. Using this model, it is demonstrated that α-PRRT based on 212Pb-SSTA results in lower absorbed doses in non-target tissue than α-PRRT based on 212Bi-SSTA for a given kidneys absorbed dose. In both approaches, the energies released in the glomeruli and proximal tubules account for 54% and 46%, respectively, of the total energy absorbed in kidneys. The 212Pb-SSTA-PBPK model accelerates the translation from bench to bedside by enabling better experimental design and by improving the understanding of the underlying mechanisms. View Full-Text
Keywords: murine PBPK model; neuroendocrine tumors; α-PRRT; in vivo alpha particle generators; [212Pb]Pb-DOTAMTATE murine PBPK model; neuroendocrine tumors; α-PRRT; in vivo alpha particle generators; [212Pb]Pb-DOTAMTATE
Show Figures

Figure 1

MDPI and ACS Style

Zaid, N.R.R.; Kletting, P.; Winter, G.; Prasad, V.; Beer, A.J.; Glatting, G. A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice. Pharmaceutics 2021, 13, 2132. https://doi.org/10.3390/pharmaceutics13122132

AMA Style

Zaid NRR, Kletting P, Winter G, Prasad V, Beer AJ, Glatting G. A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice. Pharmaceutics. 2021; 13(12):2132. https://doi.org/10.3390/pharmaceutics13122132

Chicago/Turabian Style

Zaid, Nouran R.R., Peter Kletting, Gordon Winter, Vikas Prasad, Ambros J. Beer, and Gerhard Glatting. 2021. "A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice" Pharmaceutics 13, no. 12: 2132. https://doi.org/10.3390/pharmaceutics13122132

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop